Compounded versions of GLP-1 (glucagon-like peptide-1) drugs are within easier reach of some of the nearly three-quarters of Americans who are overweight or obese
Alexandra Sowa, an obesity medicine specialist in New York, recently told the Wall Street Journal that both tapering and adding on other weight-management medications (like Qsymia) can help patients avoid the rapid rebound issues with GLP-1s
The study also showed that alluloses effects dont rely on the typical sweet taste receptors, indicating a unique biological pathway
In summary, post-therapy maintenance strategies involve self-monitoring, goal setting, and lifestyle adjustments
As always, monitor for side effects and report concerns to a clinician
Food or fluid restriction in common laboratory animals: balancing welfare considerations with scientific inquiry